Our Scientific Advisory Board
Ravi Bhatia, MSc., Scientific Director, PDMS, Janssen R&D
Christopher Bravery, Ph.D., Director, Consulting on Advanced Biologicals Ltd, United Kingdom
David Brindley, DPhil, MEng, FRSA Managing Partner, Biolacuna & Senior Research Fellow, Nuffield Department of Paediatrics, University of Oxford, United Kingdom
Bruce Levine, Ph.D., Barbara and Edward Netter Professor of Cancer Gene Therapy, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania
John McMannis, Ph.D., Executive Vice President, Manufacturing, Mesoblast
Mahendra Rao, Ph.D., M.D., Vice President, Regenerative Medicine, Q Therapeutic, Strategic Advisor, The New York Stem Cell Foundation
Jon Rowley, Ph.D., Founder & Chief Technology Officer, RoosterBio Inc.
Lior Raviv, Vice President Development, Pluristem, Israel